Abstract
Nausea and emesis are the components of a protective reflex that helps to get rid the gastrointestinal tract from toxic substances and prevents further ingestion. Various potent antiemetic drugs like 5-HT3 antagonist, D2 blockers, and H1 blockers are utilised in the treatment of chemotherapy and radiotherapy- induced nausea and vomiting, post-operative nausea and vomiting, and others. Though potent antiemetics are available, each has its own advantages and disadvantages. Hence, the search for effective antiemetic agent with good therapeutic effect and minimal side effect is in process. Experimental drugs with possible antiemetic activity with different mechanism of action are screened by using various isolated muscle preparations like guinea pig ileum, taenia caecum, colon; rat duodenum, colon, uterus; and rabbit ileum and jejunum. In vivo methods evaluate the antiemetic activity of test drug in emesis induced by chemicals, drugs, motion and by radiation. In this chapter, in vivo methods employed in the screening of antiemetic drugs are discussed in detail.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Agarwal R. Antiemetic agents. In: Gupta SK, editor. Drug screening methods. 3rd ed. New Delhi: Jaypee Brothers Medical Publishers; 2016. p. 567–77.
Andrews PLR, Horn CC. Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. Auton Neurosci. 2006;125(1–2):100–15.
Beleslin DB, Jovanović-Mićić D, Japundžić N, Nikolić SB, Samardžić R. Differential inhibition by ethanol of norepinephrine- and clonidine-induced emesis in cats. Alcohol. 1992;9(5):389–93.
Cubeddu LX. Serotonin mechanisms in chemotherapy-induced emesis in cancer patients. OCL. 1996;53(Suppl. 1):18–25.
Davies RR, Rees Davies JAE. Rabbit gastrointestinal physiology. Veterinary Clinics of North America: Exotic Animal Practice. 2003;6(1):139–53.
Fukui H, Yamamoto M. Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy. Eur J Pharmacol. 1999;372(3):261–7.
Fukui H, Yamamoto M, Sasaki S, Sato S. Possible involvement of peripheral 5-HT4 receptors in copper sulfate-induced vomiting in dogs. Eur J Pharmacol. 1994;257(1–2):47–52.
Ghosh MN. Fundamentals of experimental pharmacology. 6th ed. Kolkatta: Hilton & Company; 2015. Chapter 17, Some standard isolated muscle preparations; p.97–106
Hickman MA, Cox SR, Mahabir S, Miskell C, Lin J, Bunger A, et al. Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia TM) for the prevention of emesis and motion sickness in cats. J Vet Pharmacol Ther. 2008;31(3):220–9.
Horn CC, Kimball BA, Wang H, Kaus J, Dienel S, Nagy A, et al. Why can’t rodents vomit? A comparative behavioral, anatomical, and physiological study. Covasa M., editor. PLoS One. 2013;8(4):e60537.
King GL. Characterization of radiation-induced emesis in the ferret. Radiat Res. 1988;114(3):599.
Lau AHY, Ngan M-P, Rudd JA, Yew DTW. Differential action of domperidone to modify emesis and behaviour induced by apomorphine in the ferret. Eur J Pharmacol. 2005;516(3):247–52.
Mattsson JL, Cordts RE, Yochmowitz MG, Hardy KA. Prevention of radiation emesis in dogs by combinations of drugs. International Journal of Radiation Oncology*Biology*Physics. 1984;10(7):1067–72.
Nakayama H, Yamakuni H, Higaki M, Ishikawa H, Imazumi K, Matsuo M, et al. Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in suncus murinus and ferrets. J Pharmacol Sci. 2005;98(4):396–403.
Rudd JA, Jordan CC, Naylor RJ. The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret. Br J Pharmacol. 1996;119(5):931–6.
Takeda N, Hasegawa S, Morita M, Matsunaga T. Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol Biochem Behav. 1993;45(4):817–21.
Thawley VJ, Drobatz KJ. Assessment of dexmedetomidine and other agents for emesis induction in cats: 43 cases (2009–2014). J Am Vet Med Assoc. 2015;247(12):1415–8.
Vogel HG. Drug discovery and evaluation: pharmacological assays. 2nd ed. New York: Springer; 2002. Chapter J, Activity on the gastrointestinal tract; p. 833–905
Wynn RL, Essien E, Thut PD. The effects of different antiemetic agents on morphine-induced emesis in ferrets. Eur J Pharmacol. 1993;241(1):47–54.
Yamamoto K, Takeda N, Yamatodani A. Establishment of an animal model for radiation-induced vomiting in rats using pica. J Radiat Res. 2002;43(2):135.
Yoshino Furukawa T, Nakayama H, Kikuchi A, Imazumi K, Yamakuni H, Sogabe H, et al. Antiemetic effects of a potent and selective neurokinin-1 receptor antagonist, FK886, on cisplatin- and apomorphine-induced emesis in dogs. Biol Pharm Bull. 2013;36(6):974–9.
Zhou W, Wang J, Pan L, Qi R, Liu P, Liu J, et al. Sex and age differences in motion sickness in rats: the correlation with blood hormone responses and neuronal activation in the vestibular and autonomic nuclei. Front Aging Neurosci [Internet] 2017. Feb 15 [cited 2020 Mar 28];9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309225/
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Maharani, B. (2022). Screening Methods for the Evaluation of Antiemetics. In: Lakshmanan, M., Shewade, D.G., Raj, G.M. (eds) Introduction to Basics of Pharmacology and Toxicology. Springer, Singapore. https://doi.org/10.1007/978-981-19-5343-9_30
Download citation
DOI: https://doi.org/10.1007/978-981-19-5343-9_30
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-5342-2
Online ISBN: 978-981-19-5343-9
eBook Packages: MedicineMedicine (R0)